Modeling anti-tumor immune responses using patient-derived melanoma organoids
Kamila Kaminska, Bengt Phung, Jacob Karlström, Martin Lauss, Katja Harbst, Teresa Svensson, Kristian Pietras, Kari Nielsen, Ana Carneiro, Henrik Ekedahl, Karolin Isaksson, Göran Jönsson · 2025
Read Modeling anti-tumor immune responses using patient-derived melanoma organoids by Kamila Kaminska, Bengt Phung, Jacob Karlström, Martin Lauss, Katja Harbst, Teresa Svensson, Kristian Pietras, Kari Nielsen, Ana Carneiro, Henrik Ekedahl, Karolin Isaksson, Göran Jönsson (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12728156.txt.
Description
Kamila Kaminska and eleven co-authors grow melanoma organoids from patient tumors to study immune therapy response in this 2025 paper. Checkpoint blockade drugs can restore T cell attack on tumors, but many patients gain nothing, and the reasons stay unclear. The team built organotypic cultures from metastatic melanoma samples. The team then stimulated the T cells inside and watched what changed.
Cultures from patients who had responded to therapy showed fast T cell growth after stimulation. Cultures from resistant tissue did not, and their T cells lacked activation and checkpoint markers. That pattern hints those T cells were not tumor reactive at all. A T cell gene score that switched on in responsive cultures also tracked with longer survival in treated patients. The authors present the cultures as a lab tool for finding markers that predict who will benefit.
Catalog record
| CREATOR | Kamila Kaminska, Bengt Phung, Jacob Karlström, Martin Lauss, Katja Harbst, Teresa Svensson, Kristian Pietras, Kari Nielsen, Ana Carneiro, Henrik Ekedahl, Karolin Isaksson, Göran Jönsson |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |